There's a 16.6% increase in the price of drugs in shortage, driven mostly by an increase in the price of generics, according to a new report.

A new financial wellness partnership aims to address the "soaring rates of financial stress among employees of color" with financial technology tools, culturally relevant content and financial coaching and therapy.

Many indicators are built on human expectations, and even a lot of people can be wrong.

Coverage of Ozempic and Wegovy could conservatively drive employer spend up by 25% annually, so to give the new drugs the best opportunity to have the best effect, employers must think comprehensively and long-term.